Goodwin Advises Voyager Therapeutics in up to $875 Million Strategic Collaboration with Genzyme

Friday, February 13, 2015

Goodwin Procter advised Voyager Therapeutics on its recently announced major strategic collaboration with Genzyme to discover, develop and commercialize novel gene therapies for severe central nervous system (CNS) disorders. According to the agreement, Genzyme will make an upfront commitment of $100 million to Voyager, including $65 million in cash, a $30 million equity investment in Voyager and additional in-kind contributions. Voyager is eligible to receive future potential development and sales milestone payments of up to $745 million, as well as tiered royalties on product sales. More >>

Tags:  Goodwin Procter LLP | Boston

Shearman & Sterling Represents Initial Purchasers on $5.2 Billion (Equivalent) Bond Financing in Connection with GTECH S.p.A’s Acquisition of International Game Technology, Inc.

Friday, February 13, 2015

Shearman & Sterling represented Credit Suisse Securities (USA) LLC, Barclays Bank PLC and Citigroup Global Markets Limited as representatives of the several initial purchasers in connection with GTECH’s offering of $5.2 billion (equivalent) of temporary senior secured notes, comprising: $600 million aggregate principal amount of 5.625% senior secured notes due 2020, $1,500 million aggregate principal amount of 6.250% senior secured notes due 2022, $1,100 million aggregate principal amount of 6.500% senior secured notes due 2025, €700 million aggregate principal amount of 4.125% senior secured notes due 2020 and €850 million aggregate principal amount of 4.750% senior secured notes due 2023. More >>

Tags:  Shearman & Sterling LLP | London

Baker Botts Represents American Industrial Partners in Purchase of Anixter’s Fasteners Unit For $380 Million

Friday, February 13, 2015

Anixter International Inc. (NYSE: AXE) announced that it has entered into a definitive agreement to sell its OEM Supply – Fasteners (“Fasteners”) segment to American Industrial Partners (“AIP”) for $380 million in cash, subject to certain post-closing adjustments. The transaction, which was approved by Anixter’s Board of Directors, is expected to close during the second quarter of 2015, subject to customary closing conditions and regulatory approval. More >>

Tags:  Baker Botts L.L.P. | Houston | New York | Washington

Quinn Emanuel Opens Seattle Office Led by Former U.S. Attorney and Cyber Law Expert

Thursday, February 12, 2015

The firm has opened an office in Seattle, Washington with former U.S. Attorney, Jenny Durkan. She will serve as Global Chair of the Cyber Law and Privacy Group, and join the firm’s White Collar & Corporate Investigations practice. She will be joined by John (“Jay”) Neukom, a partner from the firm’s San Francisco Office. More >>

Tags:  Quinn Emanuel Urquhart & Sullivan, LLP | London

Crowell & Moring Expands West Coast Energy and Corporate Capabilities with Project Finance and M&A Partner Elliot Hinds

Thursday, February 12, 2015

Crowell & Moring LLP is pleased to announce the addition of partner Elliot Hinds to the firm’s Energy and Corporate groups. Hinds joins the firm from Akin Gump Strauss Hauer & Feld LLP, where he was a member of that firm’s Global Project Finance Group.

“As we continue to grow our Energy practice, a key objective is to expand our finance and transactional bench, especially on the West Coast. Elliot hits to both of these fields and perfectly complements our regulatory capabilities. It allows us to offer end-to-end service in this sector, which is of tremendous value to our clients,” said Larry F. Eisenstat, partner and chair of Crowell & Moring’s Energy Group. More >>

Tags:  Crowell & Moring LLP | Los Angeles

Arrangement of Financing for Rite Aid’s Acquisition of EnvisionRx

Thursday, February 12, 2015

On February 11, 2015, Rite Aid, one of the nation’s leading drugstore chains, and Envision Pharmaceutical Services (“EnvisionRx”), a national pharmacy benefit management company, announced that they have entered into a definitive agreement under which Rite Aid will acquire EnvisionRx in a transaction valued at approximately $2 billion. Cravath represented Citigroup, BofA Merrill Lynch, Wells Fargo and Credit Suisse as lead arrangers of an aggregate of $1.8 billion of committed debt financing. The transaction is subject to customary closing conditions, and is anticipated to close by September 2015. More >>

Tags:  Cravath, Swaine & Moore LLP | New York

Carlton Fields Jorden Burt Bolsters Its Business Transactions, International, & Real Estate Practices With Addition In New York

Thursday, February 12, 2015

Carlton Fields Jorden Burt is pleased to announce the addition of prominent corporate and real estate attorney, Frank J. Cerza, a shareholder in the firm’s New York office. Cerza is member of the firm’s Business Transactions practice group. He will also work closely with the firm’s International and Real Estate and Commercial Finance practice groups and he will chair the firm’s Italian Desk. More >>

Tags:  Carlton Fields, P.A. | New York

Simpson Thacher Advises on Apple’s $6.5 Billion Bond Offering

Wednesday, February 11, 2015

Simpson Thacher represented the underwriters, led by Goldman, Sachs & Co. and Deutsche Bank Securities Inc., in connection with the registered public offering by Apple Inc. of $6.5 billion aggregate principal amount of notes over five tranches with maturities ranging from 5 to 30 years. The net proceeds from the offering will be used for general corporate purposes, including repurchases of common stock and payment of dividends under Apple’s recently expanded program to return capital to shareholders, funding for working capital, capital expenditures and acquisitions and repayment of debt. More >>

Tags:  Simpson Thacher & Bartlett LLP | Palo Alto